|
Rate or Rhythm Control in CRT: the RHYTHMIC Study
RECRUITINGN/ASponsored by Guy's and St Thomas' NHS Foundation Trust
Actively Recruiting
PhaseN/A
SponsorGuy's and St Thomas' NHS Foundation Trust
Started2021-10-19
Est. completion2027-09-30
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04664686
Summary
70 patients with heart failure, AF and CRT with BiV\<95% will be randomised to either AF ablation or AV node ablation. Evaluation at 6 months with echocardiography and clinical assessment.
Eligibility
Age: 18 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria: * Ability to provide informed consent to participate and willing to comply with the clinical investigation plan and follow-up schedule. * QRS duration \>120ms on surface ECG, severe left ventricular systolic impairment (EF≤35%) and clinical symptoms of heart failure despite optimum medical therapy (NYHA class II-IV) at time of CRT implant or upgrade * Successful CRT implant or upgrade including atrial lead * Biventricular pacing percentage \<95% secondary to atrial fibrillation at least 3 months post implant or upgrade * Clinically indicated for AV node ablation Exclusion Criteria: * Life expectancy \<1 year * Presence of atrial or ventricular thrombus * Permanent atrial fibrillation * Mechanical aortic valve replacement * Severe peripheral vascular disease * Female participants who are pregnant, lactating or planning pregnancy during the course of the study. * Participation in other studies with active treatment / investigational arm
Conditions3
Atrial FibrillationHeart DiseaseHeart Failure
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorGuy's and St Thomas' NHS Foundation Trust
Started2021-10-19
Est. completion2027-09-30
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04664686